UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5'-Triphosphate Testing

Circulation (New York, N.Y.), 2012-01, Vol.125 (1), p.31-36

2012

Volltextzugriff (PDF)

P6-38

Heart rhythm, 2006-05, Vol.3 (5), p.S314

Flammang, Daniel

2006

Volltextzugriff (PDF)

P6-38: The ATP test: An useful test for identifying the cardio-inhibitory mechanism of syncope of unknown origin and for directing the therapy

Heart rhythm, 2006, Vol.3 (5), p.S314-S314

Flammang, Daniel

2006

Volltextzugriff (PDF)

Adenosine 5'-Triphosphate Test in the Management of Patients With Syncope

American journal of therapeutics, 2016-11, Vol.23 (6), p.e1347-e1352

2016

Volltextzugriff (PDF)

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Europace (London, England), 2013-01, Vol.15 (1), p.71-76

2013

Volltextzugriff (PDF)

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease : Beneficial effects of enoxaparin

Circulation (New York, N.Y.), 1998-07, Vol.98 (4), p.294-299

1998

Volltextzugriff (PDF)

Gender‐Related Safety and Efficacy of Cardiac Resynchronization Therapy

Clinical cardiology (Mahwah, N.J.), 2013-11, Vol.36 (11), p.683-690

2013

Volltextzugriff (PDF)

ATPace Delta TM: injectable adenosine 5'-triphosphateDiagnostic and therapeutic indications

Purinergic signalling, 2012-02, Vol.8 (1), p.57-60

2012

Volltextzugriff (PDF)

193: Determining the optimal ATP test’s end-point in syncope of unknown origin: findings from a multicenter study

Archives of Cardiovascular Diseases Supplements, 2013-01, Vol.5 (1), p.63-63

2013

Volltextzugriff (PDF)

ATPace™: injectable adenosine 5′-triphosphate: Diagnostic and therapeutic indications

Purinergic signalling, 2012-02, Vol.8 (Suppl 1), p.57-60

2012

Volltextzugriff (PDF)

The Adenosine Triphospate (ATP) Test for Evaluation of Syncope of Unknown Origin

Journal of cardiovascular electrophysiology, 2005-04, p.60118052427055

2005

Volltextzugriff (PDF)

One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients

Clinical research in cardiology, 2013-07, Vol.102 (7), p.505-511

2013

Volltextzugriff (PDF)

First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry

Europace (London, England), 2012-10, Vol.14 (10), p.1465-1474

2012

Volltextzugriff (PDF)

The Adenosine Triphospate (ATP) Test for Evaluation of Syncope of Unknown Origin

Journal of cardiovascular electrophysiology, 2005-12, Vol.16 (12), p.1388-1389

2005

Volltextzugriff (PDF)

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial

The American heart journal, 2008-09, Vol.156 (3), p.520-526

2008

Volltextzugriff (PDF)

Can adenosine 5'-triphosphate be used to select treatment in severe vasovagal syndrome?

Circulation (New York, N.Y.), 1997-08, Vol.96 (4), p.1201-1208

1997

Volltextzugriff (PDF)

Relationship between pre-implant ejection fraction and outcome after cardiac resynchronization therapy in symptomatic patients

Acta Cardiologica, 2014-08, Vol.69 (4), p.424-432

2014

Volltextzugriff (PDF)

Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study

Europace (London, England), 2005-09, Vol.7 (5), p.482-489

2005

Volltextzugriff (PDF)

Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: Analysis from the LEADER registry

Archives of cardiovascular diseases, 2013-11, Vol.106 (11), p.562-569

2013

Volltextzugriff (PDF)

192: Treatment of unexplained syncope: A multicenter, randomized trial of cardiac pacing guided by adenosine 5’-triphosphate testing

Archives of Cardiovascular Diseases Supplements, 2013-01, Vol.5 (1), p.62-63

2013

Volltextzugriff (PDF)

Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome : Preliminary results and potential therapeutic implications

Circulation (New York, N.Y.), 1999-05, Vol.99 (18), p.2427-2433

1999

Volltextzugriff (PDF)

Reproducibility of the Adenosine-5′-Triphosphate Test in Vasovagal Syndrome

Journal of cardiovascular electrophysiology, 1998-11, Vol.9 (11), p.1161-1166

1998

Volltextzugriff (PDF)

Amplitude and Direction of Atrial Depolarization Using a Multipolar Floating Catheter: Principles for a Single Lead VDD Pacing

Pacing and clinical electrophysiology, 1991-06, Vol.14 (6), p.1040-1048, Article 1040

1991

Volltextzugriff (PDF)

Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?

Cardiovascular drugs and therapy, 1989-01, Vol.2 (6), p.771-781

1989

Volltextzugriff (PDF)

Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: Relationship to plasma concentrations—a French multicenter trial

The American heart journal, 1985-09, Vol.110 (3), p.575-581

1985

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5'-Triphosphate Testing

P6-38

P6-38: The ATP test: An useful test for identifying the cardio-inhibitory mechanism of syncope of unknown origin and for directing the therapy

Adenosine 5'-Triphosphate Test in the Management of Patients With Syncope

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease : Beneficial effects of enoxaparin

Gender‐Related Safety and Efficacy of Cardiac Resynchronization Therapy

ATPace Delta TM: injectable adenosine 5'-triphosphateDiagnostic and therapeutic indications

193: Determining the optimal ATP test’s end-point in syncope of unknown origin: findings from a multicenter study

ATPace™: injectable adenosine 5′-triphosphate: Diagnostic and therapeutic indications

The Adenosine Triphospate (ATP) Test for Evaluation of Syncope of Unknown Origin

One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients

First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry

The Adenosine Triphospate (ATP) Test for Evaluation of Syncope of Unknown Origin

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial

Can adenosine 5'-triphosphate be used to select treatment in severe vasovagal syndrome?

Relationship between pre-implant ejection fraction and outcome after cardiac resynchronization therapy in symptomatic patients

Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study

Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: Analysis from the LEADER registry

192: Treatment of unexplained syncope: A multicenter, randomized trial of cardiac pacing guided by adenosine 5’-triphosphate testing

Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome : Preliminary results and potential therapeutic implications

Reproducibility of the Adenosine-5′-Triphosphate Test in Vasovagal Syndrome

Amplitude and Direction of Atrial Depolarization Using a Multipolar Floating Catheter: Principles for a Single Lead VDD Pacing

Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?

Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: Relationship to plasma concentrations—a French multicenter trial

Suchergebnisse filtern